MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

Home・Aandelen Lijst・Celsion Corp

Celsion Corp

Gesloten

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken
By Trading Economics
Werknemers	25

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-9.9M 938K
Vorige openingsprijs	0
Vorige sluitingsprijs	0

Celsion Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 okt 2025, 23:25 UTC

Belangrijke Marktbewegers

Salesforce Rises on New FY30 Financial Targets

15 okt 2025, 18:52 UTC

Winsten

Belangrijke Marktbewegers

Prologis Shares Gain on Raised Outlook, Data Center Growth

15 okt 2025, 18:30 UTC

Acquisities, Fusies, Overnames

Constellation Software to Buy U.K.'s Tecvia Holding

15 okt 2025, 17:19 UTC

Acquisities, Fusies, Overnames

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15 okt 2025, 17:11 UTC

Acquisities, Fusies, Overnames

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15 okt 2025, 23:48 UTC

Marktinformatie

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15 okt 2025, 23:38 UTC

Marktinformatie

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15 okt 2025, 22:37 UTC

Marktinformatie

Economic Stars Are Aligning for RBA -- Market Talk

15 okt 2025, 21:44 UTC

Winsten

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15 okt 2025, 20:50 UTC

Marktinformatie

Winsten

Financial Services Roundup: Market Talk

15 okt 2025, 20:44 UTC

Acquisities, Fusies, Overnames

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15 okt 2025, 20:44 UTC

Acquisities, Fusies, Overnames

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15 okt 2025, 20:43 UTC

Acquisities, Fusies, Overnames

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15 okt 2025, 20:34 UTC

Winsten

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15 okt 2025, 20:31 UTC

Acquisities, Fusies, Overnames

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15 okt 2025, 20:17 UTC

Acquisities, Fusies, Overnames

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15 okt 2025, 19:06 UTC

Winsten

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15 okt 2025, 19:04 UTC

Marktinformatie

Oil Futures Post Back-to-Back Losses -- Market Talk

15 okt 2025, 18:46 UTC

Marktinformatie

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15 okt 2025, 18:23 UTC

Winsten

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15 okt 2025, 17:37 UTC

Acquisities, Fusies, Overnames

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15 okt 2025, 17:34 UTC

Marktinformatie

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15 okt 2025, 16:57 UTC

Winsten

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15 okt 2025, 16:51 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica Doesn't Disclose Financial Details

15 okt 2025, 16:50 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15 okt 2025, 16:49 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15 okt 2025, 16:48 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15 okt 2025, 16:48 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15 okt 2025, 16:47 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica Buys Ikerian

15 okt 2025, 16:34 UTC

Marktinformatie

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Peer Vergelijking

Prijswijziging

Celsion Corp Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Celsion Corp - Dist in de afgelopen 3 maanden.

Financieel

Over Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.